✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

Santen Pharmaceutical Co Ltd

Common Name
Santen Pharmaceutical
Country
Japan
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
3,849
Ticker
4536
Exchange
TOKYO STOCK EXCHANGE
Description
Santen Pharmaceutical Co., Ltd. is a prominent pharmaceutical company focusing on ophthalmology. Established in 1890 and headquartered in Osaka, Japan, Santen specializes in the research, development,...

Santen Pharmaceutical's Climate Target Data Preview

As of 2024, Santen Pharmaceutical has disclosed 4 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 4 absolute reduction targets, signaling the company's commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Santen Pharmaceutical's climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Absolute-based Target*
Scope 3 - Purchased Goods and Services (Cat. 1)
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy/Paste is a PRO feature.
a
2025
Absolute-based Target*
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
0000000
2025
Absolute-based Target*
Scope 3 - Purchased Goods and Services (Cat. 1)
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy/Paste is a PRO feature.
a
2030
Absolute-based Target*
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
0000000
2030
*. This target is limited in scope and does not represent the company's full operational or organizational boundaries
Limited Data Preview
You are viewing a limited preview of Santen Pharmaceutical’s Climate Target dataset. The full dataset, available for download, includes detailed baseline information for both absolute and intensity targets, along with reported progress and achievement details as of 2024.
Unrestricted Access to Data and Sources
pro
Remove manual data sourcing from your workflow. Upgrade to Tracenable Pro for unrestricted access to datasets and disclosures across 8,500+ companies with over 10 years of historical coverage.
Download complete datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace values back to original sources
Formats Included
Excel
CSV
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Santen Pharmaceutical’s Climate Targets Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Santen Pharmaceutical’s data sources below and access millions more through our Disclosure Search.

a. Santen Pharmaceutical's Integrated Report 2024

Insights into Santen Pharmaceutical's Greenhouse Gas Emissions Pathways

As of 2024, Santen Pharmaceutical has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint.a

Does Santen Pharmaceutical have a target to reduce the emissions from its operations?

As of 2024, Santen Pharmaceutical has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.a

Santen Pharmaceutical's most ambitious operational target is to reduce these emissions by 50% by 2030, compared to a baseline of 37,529 Metric Tonnes of CO2 equivalent (mtCO2e) in 2019.a

As of 2023, Santen Pharmaceutical is ahead of schedule on its operational emissions reduction target, having achieved 80.42% of the planned reduction.a

Santen Pharmaceutical's Operational (Scope 1+2) Emissions Pathway

201920232025203009.5 k19 k28.5 k38 kBaselineCurrent (-40%)Target 2025 (-25%)

Does Santen Pharmaceutical have a target to reduce the emissions from its value chain?

As of 2024, Santen Pharmaceutical has set a target to reduce its value chain greenhouse gas (GHG) emissions, covering 1 out of the 15 Scope 3 categories defined by the GHG Protocol.a

Santen Pharmaceutical's most ambitious value chain target is to reduce these emissions by 15% by 2030, compared to a baseline of 114,586.13 Metric Tonnes of CO2 equivalent (mtCO2e) in 2019.a

As of 2023, Santen Pharmaceutical is ahead of schedule on its value chain emissions reduction target, having achieved 70.67% of the planned reduction.a

Santen Pharmaceutical's Value Chain (Scope 3) Emissions Pathway

2019202320252030030 k60 k90 k120 kCurrent (-11%)
Want Full Access to Santen Pharmaceutical's Climate Targets Dataset?
Sign Up